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Abstract
Background: A detrimental interaction between smoking and alcohol consumption with respect serum c-glutamyltransfer-
ase (c-GT) has recently been described. The underlying mechanisms remain unknown. The present work aimed to provide
further insights by examining similar interactions pertaining to aspartate and alanine transaminase (AST, ALT), routine liver
markers less prone to enzyme induction.
Methodology/Principal Findings: The present cross-sectional analysis was based on records from routine occupational
health examinations of 15,281 male employees predominantly of the construction industry, conducted from 1986 to 1992 in
Southern Germany. Associations of smoking intensity with log-transformed activities of c-GT, AST, and ALT were examined
in regression models adjusted for potential confounders and including an interaction of smoking with alcohol consumption
or body mass index (BMI). Statistically significant interactions of smoking were observed with both alcohol consumption
(AST and ALT, each with P,0.0001) and BMI (AST only, P,0.0001). The interactions all were in the same directions as for c-
GT, i.e. synergistic with alcohol and opposite with BMI.
Conclusion: The patterns of interaction between smoking and alcohol consumption or BMI with respect to AST and ALT
resembled those observed for c-GT. This renders enzyme induction a less probable mechanism for these associations,
whereas it might implicate exacerbated hepatocellular vulnerability and injury.
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Introduction
Routine markers of liver function and damage [1,2], in
particular c-glutamyltransferase (c-GT), aspartate and alanine
transferase (AST and ALT, respectively), have attracted substan-
tial interest in recent years because numerous studies suggested a
predictive potential regarding a variety of clinical outcomes in
both generally healthy and in patient cohorts [3–12]. Knowledge
of causal relationships linking liver enzymes with clinical outcomes
remains very limited, and better understanding the role of disease
risk factors in the inter-individual variation of liver enzyme
activities would be of high interest.
In a recent study, we found a detrimental synergistic interaction
between smoking and alcohol consumption with respect to the
elevation of serum c-GT [13]. Such an interaction would apply to
a large number of individuals due to the high frequency and co-
occurrence of tobacco and alcohol use and abuse. Intriguingly, we
subsequently obtained evidence that the interaction between
smoking and body mass index (BMI), another important
determinant of serum c-GT, might be opposite to the smokin-
g6alcohol interaction, i.e. smoking intensity was positively
associated with c-GT only in subjects with low rather than high
BMI, although BMI itself—just like alcohol consumption—is
positively associated with higher serum c-GT [14].
In the present work, we extended our considerations to AST
and ALT. If the interaction effects previously described for c-GT
were primarily due to enzyme induction, a mechanism known to
apply predominantly to c-GT [15], they should not or not to the
same extent become apparent in analyses of AST and ALT.
Serum activities of both these enzymes, however, respond well to
compromised liver cell integrity [1]. Thus, the presence of similar
interactions as observed for c-GT would suggest that an escalation
of tissue damage in the central homeostatic organ plays a relevant
role in the observed associations.
Methods
Ethics Statement
Whereas participation in the occupational health exams
forming the basis of this work is non-mandatory for most
occupation groups according to German occupational safety laws,
anonymised data obtained in such exams is to be collected and
analysed scientifically. Thus, no additional specific informed
consent was required for analysis of anonymised data in this
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boards of Heidelberg University, Ulm University, and by the
Ministry of Social Affairs of the State of Baden-Wu ¨rttemberg. As
the ethics boards generally do not express approval of each
individual aspect of the study, but rather—if necessary—request
individual aspects of the study to be improved, the need for
informed consent was not explicitly addressed in their approval of
the study protocol.
Design, Setting, and Participants
Data used in the present study originated from routine
occupational health examinations (April 1986 to December
1992), for which records were obtained from the Workmen’s
Compensation Board for Construction Workers in Wu ¨rttemberg
in South Germany. Details of the study design have been reported
previously [4,11,14]. Only males were included, and the study
population is representative for a large number of construction
workers in Germany.
Data Collection
The health examinations were conducted by experienced
occupational health professionals in a standardised manner. They
included taking a blood sample for routine laboratory analysis. In
addition, participants were asked to fill out a standardised
questionnaire covering occupational information, nationality,
health behaviour (smoking, alcohol consumption), prevalent
disease (coded according to ICD-9), and body weight and height.
Serum activities of liver enzymes were determined centrally as part
of the routine exam, using a Hitachi 705/717 instrument working
at 25uC, with upper reference limits of 28, 18, and 22 U/L for c-
GT, AST, and ALT, respectively (corresponding to approx. 49,
38, and 41 U/L when converted to 37uC [16]).
Statistical Analysis
The study population was first described regarding the
distribution of important potential confounding characteristics,
including the medians (interquartile ranges) and frequencies of
above normal activities of the three enzymes within each
covariable stratum. The statistical significance of differences
between the strata was assessed by Kruskal-Wallis testing.
Interactions between smoking intensity and alcohol consump-
tion or BMI on liver enzyme activities were examined using linear
regression models adjusted for age (,25, 25–34, 35–44, 45–54,
$55 years), alcohol consumption (none, occasional, 1–30, 31–60,
61–90, .90 g/day), BMI (,25, 25–,30, $30 kg/m
2), nationality
(German, Italian, Turkish, Yugoslavian, other), professional group
(bricklayer, carpenter, office worker, painter, plasterer, plumber,
unskilled worker), diabetes (ICD-9 250), hypertension (ICD-9 401-
405), and ischemic heart disease (ICD-9 410-414). For these
regression models, former smokers and consumers of tobacco
products other than cigarettes were excluded (these subjects form a
subgroup that must be considered highly heterogeneous and do
not readily fit into an analysis of current smoking exposure), and
smoking was coded as a trend variable taking on the median
smoking intensity in cigarettes per day (cpd) within each smoking
stratum (these medians were 0, 10, 20, and 30 cpd, in the
categories of never smokers, smokers of ,20, 20, and .20 cpd,
respectively). The interaction was judged based on the significance
of the interaction term between the smoking trend variable and
the alcohol consumption or BMI stratum variable (tests with 5 and
2 degrees of freedom, respectively).
In the linear regression models, liver enzymes were natural log-
transformed throughout, because all three showed a right-skewed
distribution. For sensitivity analyses, subjects with any of the liver
enzyme activities, BMI, alcohol consumption or smoking intensity
beyond the 99
th or 95
th percentile were excluded. We furthermore
explored the impact of estimating the smoking trend association in
models fitted separately to each BMI or alcohol stratum while
including age, age
2, BMI, BMI
2, and alcohol consumption as
continuous variables. All statistical analyses were conducted using
SAS 9.2 (SAS Institute, Cary/NC), using two-sided tests and
a=5%.
Results
Descriptive Analysis
A total of 22,014 health exam records included measurements
of all three liver markers. After excluding those individuals lacking
data on smoking (or smoking tobacco products other than
cigarettes), alcohol consumption, or BMI, 15,281 subjects
remained in our analysis set. This was a slightly different analysis
population than in the in-depth report focussed entirely on c-GT,
which explains minimal differences of the present compared to the
previous c-GT results [14].
Median activities of the markers by covariable categories are
reported in Table 1. Distributions of all three markers were right-
skewed, the 95th and 99th percentiles being 96 and 248, 25 and
51, and 38 and 66 for c-GT, AST and ALT, respectively. The
markers were strongly correlated with Spearman coefficients of
0.52 (c-GT, AST), 0.63 (c-GT, ALT), and 0.70 (AST, ALT),
which remained essentially the same when controlling for age.
Above-normal levels were most prevalent for c-GT, and least
for AST. Associations of the three markers were apparent with
most major participant characteristics, and were sometimes very
pronounced (Table 1). Both AST and ALT appeared positively
associated with alcohol consumption and BMI.
Interaction Analyses
Geometric mean activities of the liver enzymes by smoking6al-
cohol drinking strata are shown in Figure 1 (for cell sizes,
medians and interquartile ranges of the activities, see Table S1).
An increase across rising alcohol consumption intensity was
apparent for all three enzymes, but smoking effects appeared less
consistent in these crude analyses. However, there seemed to be
some tendency of smoking intensity to be associated negatively
with AST and ALT activities in subjects not drinking alcohol and
positively or with inconsistent pattern in subjects with higher
alcohol consumption. Former smokers tended to show the highest
concentration of each marker within most drinking categories.
The interaction of smoking6BMI regarding geometric mean
activities of the three markers is depicted in Figure 2 (for cell
sizes, medians and interquartile ranges of the activities, see Table
S2). For c-GT and ALT, there was a clear positive association
with BMI. In subjects with BMI ,25 kg/m
2, a strong positive
association with smoking intensity was seen for c-GT, whereas the
association with AST was much less pronounced and the one with
ALT hardly visible. In obese participants, c-GT was lowest in
never smokers, but otherwise there was little evidence for an
association between the markers and smoking.
In linear regression models predicting the log-transformed
marker activities from smoking6alcohol consumption intensity or
smoking6BMI strata, adjusted for age group and BMI (in case of
the smoking6alcohol interaction) or alcohol drinking intensity (in
case of the smoking6BMI interaction), the interaction tendencies
described in the preceding paragraph became clearer (not shown).
Compared to never-smokers with BMI,25 kg/m
2, AST and ALT
appeared to be less elevated in heavily smoking obese than in
never-smoking obese subjects. The estimates hardly changed when
Smoking Interactions: AST and ALT versus c-GT
PLoS ONE | www.plosone.org 2 November 2011 | Volume 6 | Issue 11 | e27951Table 1. Median and interquartile range (IQR) of serum c-GT, AST and ALT (at 25uC) in n=15281 working age males in Southern
Germany, according to sociodemographics, occupation, nationality, life-style factors and prevalent diseases.
Characteristic n % Serum c-GT (U/L) Serum AST (U/L) Serum ALT (U/L)
Median (IQR)
.28 U/
L( % ) P
a Median (IQR)
.18 U/
L( % ) P
a Median (IQR)
.22 U/
L( % ) P
a
Total
population
15281 100.0 17.0 (12.0–31.0) 28.3 na 11.0 (9.0–14.0) 10.8 na 14.0 (11.0–20.0) 20.0 na
Age ,25 years 1598 10.5 12.0 (9.0–17.0) 8.9 10.0 (9.0–12.0) 5.7 11.0 (9.0–15.0) 9.3
25–34 years 4339 28.4 15.0 (11.0–26.0) 22.4 11.0 (9.0–14.0) 10.1 14.0 (11.0–21.0) 21.2
35–44 years 2904 19.0 20.0 (13.0–38.0) 35.0 11.0 (9.0–14.0) 13.0 16.0 (12.0–23.0) 26.2
45–54 years 4333 28.4 20.0 (13.0–38.0) 35.2 11.0 (9.0–14.0) 12.4 15.0 (11.0–21.0) 20.8
$55 years 2107 13.8 20.0 (13.0–34.0) 32.0 ,0.0001 11.0 (9.0–13.0) 9.7 ,0.0001 14.0 (10.0–19.0) 15.6 ,0.0001
Nationality German 11595 76.1 18.0 (12.0–33.0) 30.1 11.0 (9.0–14.0) 11.1 14.0 (11.0–20.0) 20.1
Italian 1074 7.0 17.0 (12.0–29.0) 25.3 11.0 (9.0–14.0) 10.1 15.0 (11.0–21.0) 21.3
Turkish 814 5.3 12.0 (9.0–17.0) 7.0 10.0 (8.0–12.0) 3.3 12.0 (9.0–17.0) 10.7
Yugoslavian 1295 8.5 18.0 (11.0–32.0) 28.6 11.0 (9.0–15.0) 13.1 15.0 (11.0–22.0) 24.0
Other 459 3.0 16.0 (11.0–30.0) 26.4 ,0.0001 11.0 (9.0–13.0) 10.0 ,0.0001 14.0 (11.0–20.0) 17.9 ,0.0001
Occupational
group
Bricklayer 4714 30.8 19.0 (12.0–34.0) 31.2 11.0 (9.0–14.0) 11.7 15.0 (11.0–21.0) 21.2
Carpenter 2070 13.5 16.0 (11.0–28.0) 24.8 11.0 (9.0–14.0) 8.8 14.0 (11.0–20.0) 17.7
Painter 2223 14.5 17.0 (12.0–32.0) 28.5 11.0 (9.0–13.0) 9.9 14.0 (10.0–20.0) 19.9
Plasterer 1560 10.2 18.0 (11.0–33.0) 30.1 11.0 (9.0–14.0) 11.2 14.0 (10.0–21.0) 20.9
Plumber 2346 15.4 17.0 (11.0–29.0) 26.0 11.0 (9.0–13.0) 9.4 14.0 (11.0–20.0) 19.1
Unskilled 2167 14.2 17.0 (11.0–30.0) 27.2 11.0 (9.0–14.0) 13.4 14.0 (11.0–20.0) 20.4
Office 201 1.3 15.0 (11.0–26.0) 19.9 ,0.0001 10.0 (9.0–12.0) 6.0 ,0.0001 13.0 (9.0–19.0) 14.9 0.0004
Cigarette
smoking
Never 4121 27.0 16.0 (11.0–27.0) 22.7 11.0 (9.0–13.0) 8.2 14.0 (11.0–20.0) 18.7
,20 cpd 2923 19.1 16.0 (11.0–29.0) 25.1 11.0 (9.0–13.0) 9.8 14.0 (10.0–20.0) 18.6
20 cpd 3689 24.1 17.0 (12.0–32.0) 28.5 11.0 (9.0–14.0) 11.2 14.0 (10.0–19.0) 17.4
.20 cpd 1922 12.6 20.0 (13.0–40.0) 36.2 11.0 (9.0–15.0) 15.8 15.0 (11.0–21.0) 22.5
Formerly 2626 17.2 20.0 (13.0–36.0) 34.5 ,0.0001 11.0 (9.0–14.0) 11.6 ,0.0001 16.0 (12.0–23.0) 25.4 ,0.0001
Alcohol
consumption
None 1762 11.5 12.0 (9.0–18.0) 8.7 10.0 (8.0–12.0) 4.1 13.0 (10.0–17.0) 11.9
Occasionally 6062 39.7 15.0 (10.0–24.0) 18.2 10.0 (9.0–13.0) 5.5 13.0 (10.0–19.0) 15.7
1–30 g/d 1569 10.3 16.0 (11.0–27.0) 22.4 10.0 (9.0–13.0) 6.9 14.0 (10.0–19.0) 17.3
31–60 g/d 2915 19.1 21.0 (13.0–38.0) 36.1 11.0 (9.0–14.0) 11.7 15.0 (11.0–21.0) 22.2
61–90 g/d 1455 9.5 28.0 (16.0–52.0) 49.8 13.0 (10.0–17.0) 20.0 16.0 (12.0–24.0) 28.5
.90 g/d 1518 9.9 38.0 (21.0–74.0) 61.9 ,0.0001 14.0 (11.0–21.0) 32.9 ,0.0001 18.0 (13.0–28.0) 37.1 ,0.0001
Body Mass
Index
,25 kg/m
2 6232 40.8 13.0 (10.0–22.0) 17.8 11.0 (9.0–13.0) 10.3 12.0 (9.0–16.0) 11.3
25–,30 kg/m
2 6899 45.1 20.0 (13.0–34.0) 32.3 11.0 (9.0–14.0) 10.3 15.0 (12.0–21.0) 22.2
$30 kg/m
2 2150 14.1 26.5 (17.0–46.0) 46.2 ,0.0001 12.0 (10.0–15.0) 13.9 ,0.0001 19.0 (14.0–27.0) 38.1 ,0.0001
Prevalent
diabetes
no 14617 95.7 17.0 (11.0–31.0) 27.4 11.0 (9.0–14.0) 10.5 14.0 (10.0–20.0) 19.5
yes 664 4.3 28.0 (17.0–55.0) 48.6 ,0.0001 11.0 (9.0–15.0) 17.0 0.0025 17.0 (12.0–25.0) 31.3 ,0.0001
Prevalent
ischemic
heart disease
no 15057 98.5 17.0 (11.0–31.0) 28.2 11.0 (9.0–14.0) 10.8 14.0 (11.0–20.0) 20.0
yes 224 1.5 24.0 (14.5–41.0) 37.9 ,0.0001 11.0 (9.0–14.0) 8.5 0.51 15.0 (12.0–21.0) 21.9 0.029
Prevalent
hypertension
no 12166 79.6 16.0 (11.0–27.0) 23.5 11.0 (9.0–13.0) 9.0 14.0 (10.0–19.0) 17.1
yes 3115 20.4 27.0 (16.0–51.0) 47.1 ,0.0001 12.0 (10.0–16.0) 17.7 ,0.0001 17.0 (12.0–25.0) 31.2 ,0.0001
aP-value of Kruskal-Wallis test.
doi:10.1371/journal.pone.0027951.t001
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Table 1.
Table 2 presents the fully adjusted main models of the present
analyses, in which the association of smoking intensity coded as a
trend variable (see Methods section) with each serum marker was
evaluated along with its interaction with alcohol consumption or
BMI. These models suggested pronounced and mostly statistically
significant interaction effects for AST and ALT. The interactions
were directionally similar to those described for c-GT. However,
whereas smoking showed no main effect on c-GT in alcohol
abstinent and obese subjects, and a positive association in heavy
drinkers or subjects with normal weight, the patterns were
somewhat shifted for AST and ALT, for which there was a
negative association of smoking intensity with the respective
marker in alcohol abstinent and obese subjects, and a positive
(AST) or no association (ALT) in heavy drinkers or normal weight
subjects. When both interaction terms were included together in
the models, the individual P-values hardly changed (not shown).
Sensitivity Analyses
When subjects with smoking intensity, alcohol consumption
intensity, BMI, c-GT, AST, or ALT beyond the 99th percentile
(50 cpd, 200 g/day, 36.5 kg/m
2, 248 U/L, 51 U/L, 66 U/L)
were excluded for the purpose of sensitivity analyses, the Table 2
results hardly changed (details not shown). The same was true for
using a the 95th percentile as cutoff (40 cpd, 125 g/day, 32.5 kg/
m
2, 96 U/L, 25 U/L, 38 U/L). Whereas the interactions with
respect to c-GT lost statistical significance in the latter models
limited to 10,694 subjects, the estimated associations and
interaction patterns generally remained similar in these analyses.
The smoking trend estimates obtained in models stratified on BMI
or alcohol consumption category and treating certain covariables
as continuous and potentially non-linear predictors as detailed
above were overall in line with the main analyses’ results (not
shown).
Discussion
In this large cross-sectional study, interaction effects of smoking
with both alcohol consumption intensity and BMI were observed
with respect to serum activities of AST and ALT. Advancing our
understanding of the relationships between classical disease risk
factors and liver enzyme levels is important, because especially c-
GT is more and more seen as a cardiovascular risk marker, The
pattern of the heterogeneity of AST and ALT associations was
directionally similar to the interactions recently described for c-
Figure 1. Geometric mean serum activities of c-GT (grey bars), AST (hatched bars) and ALT (white bars; all in U/L measured at 256C)
in 15,281 men in Germany, by alcohol consumption intensity (bottom row) and smoking behaviour (cpd=cigarettes per day).
doi:10.1371/journal.pone.0027951.g001
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enzyme induction, these observations are more in line with the
hypothesis that the varying associations of smoking with liver
enzymes across alcohol or BMI strata could be due to varying
levels of hepatocellular vulnerability and injury.
The crude associations of the main exposures in our study were
similar to previous reports. This pertains in particular to the
positive associations of alcohol consumption intensity and BMI
with the liver enzymes, for which the literature appears fairly
consistent [17–22]. Some, but not all [21], previous studies
suggested a stronger association of alcohol with liver enzymes in
subjects with higher BMI [20,23]. The associations with prevalent
diseases already were described and discussed in the context of an
earlier analysis of a subcohort of the present study [4]. An excess in
particular of c-GT in former smokers has also been described
previously [13,24]. This could be due to weight gain after
Figure 2. Geometric mean serum activities of c-GT (grey bars), AST (hatched bars) and ALT (white bars; all in U/L measured at 256C)
in 15,281 men in Germany, by body mass index and smoking behaviour (cpd=cigarettes per day).
doi:10.1371/journal.pone.0027951.g002
Table 2. Fully adjusted association (see footnote) of smoking intensity with liver enzymes by drinking and body mass index strata,
estimated in linear regression models predicting natural log-transformed enzyme activities.
Interaction
stratum
Change in c-GT
per 10 cpd
Change in AST
per 10 cpd
Change in ALT
per 10 cpd
D% (95% CI) P
a D% (95% CI) P
a D% (95% CI) P
a
Alcohol
consumption
None 0.76 (22.39 to 4.01) 24.45 (26.14 to 22.73) 26.00 (28.07 to 23.88)
Occasional 4.35 (2.49 to 6.25) 20.93 (21.93 to 0.08) 21.77 (23.00 to 20.52)
1–30 g/day 5.49 (1.74 to 9.37) 0.11 (21.90 to 2.16) 22.33 (24.77 to 0.18)
31–60 g/day 5.90 (3.14 to 8.74) 1.48 (20.02 to 2.99) 20.95 (22.77 to 0.90)
61–90 g/day 8.41 (4.60 to 12.4) 4.17 (2.10 to 6.29) 1.29 (21.22 to 3.87)
.90 g/day 7.76 (4.02 to 11.6) 0.028 5.30 (3.23 to 7.40) ,0.0001 1.50 (20.98 to 4.04) ,0.0001
Body mass index ,25 kg/m
2 7.24 (5.36 to 9.15) 2.05 1.05 to 3.07) 20.67 (21.89 to 0.57)
25–,30 kg/m
2 3.98 (2.25 to 5.74) 20.58 21.51 to 0.37) 22.23 (23.37 to 21.07)
$30 kg/m
2 1.95 (21.03 to 5.03) 0.0045 22.24 23.87 to 20.59) ,0.0001 22.25 (24.27 to 20.19) 0.14
aP-value of interaction test.
Note. All six models were adjusted for age, nationality, occupational group, alcohol consumption, body mass index, diabetes, ischemic heart disease, and hypertension
(n=12,615; former smokers and subjects with missing nationality were excluded).
doi:10.1371/journal.pone.0027951.t002
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smoking e.g. due to particular health issues that might be
associated with liver enzyme elevations.
Previous studies regarding the main effect of smoking have
yielded mixed results, e.g. suggesting a positive association only in
women [19], or finding an effect only on c-GT but neither on AST
nor ALT [17,18]. Such inconsistent results, of course, would not be
overly unexpected if taking our main findings into account, which
suggested pronounced effect heterogeneity of the association of
smoking with liver enzymes to occur depending on alcohol
consumption and BMI. Investigations of potential interactions
between smoking and alcohol drinking with respect to serum c-GT
are very scarce [13,24,25]. Corresponding interaction analyses
regardingASTandALTalsoappeartobe limited toone study[24].
In one previous investigation on smoking6alcohol interactions
and serum transaminases [24], there also was a significant inverse
association of smoking intensity with AST only insubjects with no or
low alcohol consumption (which could mean that effects of smoking
on this marker are essentially overruled by the stronger effects of
alcohol consumption), but no association was found between
smoking and ALT; BMI was controlled for, but its interaction with
smoking was not investigated in that particular or indeed any study
that has come to our attention. The authors of this previous study
hypothesized that their finding of a smoking-associated elevation
onlyinc-GT might have been due to nicotine inducing c-GT.In the
other study of interest, the c-GT interaction also was found, as was
an inverse association of smoking with AST [25]. In contrast to the
latter, the association of smoking with c-GT was substantially
reduced when adjusting for the inflammatory marker C-reactive
protein, which—contrary to the previously cited study—would
suggest that smoking effects on c-GT mainly reflect inflammatory
oxidative stress with an exacerbation of similar effects of alcohol in
the situation of higher intensity co-consumption [13,25].
The associations discovered in our data should allow some
further insights in this regard, as pronounced and heterogeneous
associations were observed between smoking and all three
enzymes examined. The very robust patterns of interaction over
strata of alcohol consumption or BMI with respect to AST and
ALT paralleled those for c-GT, suggesting that enzyme induction
applying selectively to c-GT [26,27] would be at least insufficient
to explain the observed associations. Interestingly, in subjects with
alcoholic fatty liver, serum AST and ALT may rise in the absence
of alterations at the hepatic level [15]. The interactions in similar
directions and extents in comparison to c-GT might suggest that
liver injury and loss of hepatocellular integrity—potentially
affecting serum activities of all three enzymes alike—should be
considered as a pathophysiological mechanisms involved in
creating these interaction patterns.
Whereas the arguments above would fit the explanation
previously put forward regarding the smoking6alcohol interaction
with respect to c-GT, namely excessive combined oxidative stress
resulting from co-consumption [13], it appears more difficult to
explain the opposite interaction pattern for smoking6BMI. We
earlier considered dilution effects of a higher body volume as a
possible mechanism for weaker associations in obese. As obesity
itself is associated with increased oxidative stress, oxidative stress
would appear an unlikely explanation for the opposite direction-
ality of effect modification across BMI in comparison to alcohol
strata [28]. Interestingly, however, a recent study found smoking
to be associated with a higher risk for lung cancer in subjects with
lower BMI [29], and the authors cited reports of inverse
correlations between BMI and markers of oxidative DNA damage
to support the results’ biological plausibility. Arguing along these
lines, the interaction patterns observed in the present study—
parallel across markers and opposite with respect to alcohol and
BMI—would be in line with smoking-related serum c-GT
elevations being at least partially due to liver injury rather than
enzyme induction, and excess oxidative stress could be the
underlying cause of this loss of hepatocellular integrity, exacer-
bated—be it in absolute terms or relative to some potentially
altered hepatocellular vulnerability threshold—either by high
alcohol consumption or by low body weight. The previous report
[25] describing that the association between smoking and AST is
not affected by adjustment for C-reactive protein would suggest
that the mechanisms involved in the loss of hepatocellular integrity
go beyond inflammatory processes readily assessed by this marker.
A number of limitations should be considered when judging the
present study’s results. Although exposure assessment was conducted
in a highly standardized way, smoking and drinking behaviour were
determined exclusively by self-report. It appears, however, not likely
that misreporting compromised the validity of our findings, as only
peculiar patterns of pronouncedly differential misreporting according
to c-GT, alcohol consumption and BMI could theoretically create
such complex association and interaction patterns as observed. We
adjusted for a variety of important confounders, including continuous
and non-linear effects in sensitivity analyses, yet we cannot rule out
some residual confounding due to unknown or unmeasured factors.
Physical activity would be such a potentially interesting variable, but
the fairly homogenous nature of the study population rendered a
serious distortion due to this or other confounders rather unlikely.
Note, however, that the potential for confounding is limited, if a
variable is only associated with enzyme activities, but is not a strong
causal factor of the exposures of interest. For example, an additional
adjustment of our models for presence or absence of regular
medication—which can be considered a causal factor for liver
enzyme elevations—had no impact on any of the estimates in Table2
(data not shown). Underlying liver disease such as viral hepatitis,
primary biliary cirrhosis, or autoimmune hepatitis was reported only
in a very small number (,0.3%) of subjects in our cohort of workers
employed in physically intensive professions, and thus was not
considered in the analyses. The role of liver fat accumulation for the
associations described in the present study could possibly be better
understood by using imaging techniques such as ultrasound. This was
not feasible in the present study setting, and only serum cholesterol,
triglycerides, and fasting glucose were available as general metabolic
indicators. Additional adjustment of our main regression analyses for
these markers did not relevantly change the results (data not shown).
Finally,longitudinal repeat measurements of the parametersanalysed
would have considerably strengthened attempts to draw causal
conclusions, but were beyond the scope of this study. Finally,
additional blood sampling for the determination e.g. of C-reactive
protein was not possible in our study design.
Inconclusion,the comparative analysisof bothenzymes(c-GT vs.
AST and ALT) and interaction exposures (alcohol consumption vs.
BMI) in the present study allowed us to suggest some pathophys-
iological explanations for the previously described interactions of
classical risk factors as determinants of serum c-GT. The findings
tentatively implicated hepatic injury as a main mechanism involved
in the detrimental smoking6alcohol interaction with respect to c-
GT. However,given thescarcity of prior investigationsintopotential
interactions between smoking and alcohol consumption or BMI,
efforts to replicate the patterns described here in independent
epidemiological cohorts should be undertaken. Furthermore,
especially the intriguing interactions and negative associations of
smoking with AST and ALT deserve attention also from molecular
and laboratory scientists. In the context of future clinical and
nutritional approaches, the role of liver fat contents for these
associations and interactions would be a highly interesting, though
Smoking Interactions: AST and ALT versus c-GT
PLoS ONE | www.plosone.org 6 November 2011 | Volume 6 | Issue 11 | e27951resource-demanding [30] research topic, with great potential to
advance our causal understanding of these classical, yet newly
discovered serum markers of liver function and integrity.
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